⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,851.39
−0.27%
FTSE ADX
9,783.24
−0.26%
TASI
10,123.62
−0.65%
QE Index
8,632.66
−0.01%
S&P 500
7,690.73
+0.41%
Nasdaq 100
29,529.34
+1.17%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,966.09
−0.27%
DFM:EMIRATESNBD
AED 31.50
−0.25%
ADX:IHC
AED 352.00
−0.17%
SAU:2222
SAR 25.80
+0.00%
DSMD:QNBK
QAR 15.66
+2.29%
NAS:NVDA
$217.09
+1.38%
NYSE:TSM
$420.22
+1.84%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 299.47
+0.12%
Gold
$4,139.62
−0.03%
Brent
$109.22
−0.54%
BTC
$81,980.06
−0.04%
ETH
$2,404.04
−0.14%
DFM General
5,851.39
−0.27%
FTSE ADX
9,783.24
−0.26%
TASI
10,123.62
−0.65%
QE Index
8,632.66
−0.01%
S&P 500
7,690.73
+0.41%
Nasdaq 100
29,529.34
+1.17%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,966.09
−0.27%
DFM:EMIRATESNBD
AED 31.50
−0.25%
ADX:IHC
AED 352.00
−0.17%
SAU:2222
SAR 25.80
+0.00%
DSMD:QNBK
QAR 15.66
+2.29%
NAS:NVDA
$217.09
+1.38%
NYSE:TSM
$420.22
+1.84%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 299.47
+0.12%
Gold
$4,139.62
−0.03%
Brent
$109.22
−0.54%
BTC
$81,980.06
−0.04%
ETH
$2,404.04
−0.14%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Closed
🇸🇦
Saudi Arabia
Tadawul · TASI
Closed
🇶🇦
Qatar
QSE · QE General
Closed
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Closed
🇮🇳
India
NSE · BSE · Nifty 50
Closed
🇵🇰
Pakistan
PSX · KSE-100
Closed
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
Markets
›
United States
› NAS
› AXSM
A
Axsome Therapeutics Inc
NAS:AXSM
Healthcare
NASDAQ:NBI
NASDAQ:NQUSMG
$155.81
−0.85%
At close
At close · Tue 20 Oct · ≈
AED 572.21
· Market cap
$8.16B
· Next earnings
Mon 2 Nov
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
Ownership
Options
Shorts
News
Profile
Axsome Therapeutics Inc · News · TradingHolo
AXSM news
Headlines tagged to this company
FI
Grant & Eisenhofer Appointed Lead Counsel in Lawsuit Alleging CIBC and RBC Manipulated Quantum BioPharma Stock
FinanceWire · 11 d ago
DO
Axsome Therapeutics Price Target Cut to $295.00/Share From $297.00 by RBC Capital
Dow Jones Newswires · 11 d ago
GL
Axsome Therapeutics to Report Third Quarter 2026 Financial Results on November 2
GlobeNewswire · 13 d ago
DO
Axsome Therapeutics Is Maintained at Buy by Deutsche Bank
Dow Jones Newswires · 20 d ago
BE
Biotech ETF XBI Hits an Interest Rate Wall as 40+ Catalysts Approach
benzinga · 24 d ago
GL
Axsome Therapeutics Announces Results of the Shared Goals Survey of Caregivers of Patients with Alzheimer’s Disease Agitation Presented at Psych Congress 2026 in Connection with World Alzheimer’s Day
globenewswire · 29 d ago
MA
Axsome Therapeutics Highlights Auvelity Growth, Pipeline Progress at H.C. Wainwright Conference
marketbeat · 31 d ago
GL
Axsome Therapeutics Presents Ten Posters Exemplifying its Innovative Psychiatry and Neurology Portfolio at Psych Congress 2026
globenewswire · 33 d ago
SE
Goldman rebalances its long duration stock basket
seekingalpha · 36 d ago
ST
AXSM Jumps 6% As Mizuho Calls Auvelity’s Alzheimer’s Launch A ‘Strong Start’
stocktwits · 38 d ago
SE
Axsome rises on Auvelity prescription data
seekingalpha · 38 d ago
GL
Axsome Therapeutics to Participate in Upcoming Investor Conferences
globenewswire · 48 d ago
ZA
Axsome Begins Phase III Study on AXS-05 for Smoking Cessation
zacks · 48 d ago
GL
Axsome Therapeutics Initiates SUMMIT Phase 3 Trial of AXS-05 in Smoking Cessation
globenewswire · 50 d ago
ZA
Axsome's Q2 Earnings Meet Estimates, Auvelity Drives Y/Y Revenues
Zacks Investment Research · 69 d ago
SE
Axsome Therapeutics Q2 Earnings Review: I Just Can't See The Value Proposition
Seeking Alpha · 69 d ago
SE
Axsome Therapeutics, Inc. (AXSM) Q2 2026 Earnings Call Transcript
Seeking Alpha · 70 d ago
GL
Axsome Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
GlobeNewsWire · 71 d ago
DE
Assenagon Asset Management S.A. Cuts Stock Holdings in Axsome Therapeutics, Inc. $AXSM
Defense World · 73 d ago
End of the feed